Ginseng Claims Investigation By FDA, FTC Sought By CSPI
This article was originally published in The Tan Sheet
Executive Summary
A government regulatory review of claims for ginseng dietary supplement and functional food products is requested by the Center for Science in the Public Interest in recent letters to FDA and the Federal Trade Commission.